© 2020 MJH Life Sciences and . All rights reserved.
Dr. Paul Chapman on the Choice to Pursue Adjuvant Immunotherapy for Melanoma Patients
June 19, 2019
Cancer Network spoke with Paul B. Chapman, MD, of Memorial Sloan Kettering Cancer Center, about pursuing adjuvant immunotherapy for patients with melanoma.
Cancer Network spoke with Paul B. Chapman, MD, of Memorial Sloan Kettering Cancer Center, about pursuing adjuvant immunotherapy for patients with melanoma.